H. Varmus

Molecular Biology · 2001–2016

A researcher in the Science corpus: 11 papers; trusts 3 researchers and is trusted by 1 researcher here, as inferred from the citation graph.

Subfields

• Molecular Biology — 71 citations into it

Whom H. Varmus trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Paul Polakis

Who trusts H. Varmus overall

1. William Pao

Papers from H. Varmus's perspective

Ordered by how strongly the researchers H. Varmus trusts endorse each paper. Same corpus, a different order for every researcher.

1. Wnt signaling in oncogenesis and embryogenesis--a look outside the nucleus. (Science)
2. Dishevelled controls cell polarity during Xenopus gastrulation (Nature)
3. Wnt signaling and cancer. (Genes & Development)
4. Synergistic Activation of the Wnt Signaling Pathway by Dvl and Casein Kinase Iε* (Journal of Biological Chemistry)
5. Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification (Science)
6. New guidelines to evaluate the response to treatment in solid tumors (Journal of the National Cancer Institute)
7. EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. (Proceedings of the National Academy of Sciences of the United States of America)
8. Gefitinib-Sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic Pathways (Science)
9. A Unique Structure for Epidermal Growth Factor Receptor Bound to GW572016 (Lapatinib) (Cancer Research)
10. Structure of the Epidermal Growth Factor Receptor Kinase Domain Alone and in Complex with a 4-Anilinoquinazoline Inhibitor* (Journal of Biological Chemistry)

Their papers

• Somatic mutations affect key pathways in lung adenocarcinoma (2008) — 2,751 citations
• Characterizing the cancer genome in lung adenocarcinoma (2007) — 1,146 citations
• KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib (2005) — 1,447 citations
• The Knockout Mouse Project (2004) — 618 citations
• Rescuing US biomedical research from its systemic flaws (2014) — 719 citations
• Toward a Shared Vision for Cancer Genomic Data (2016) — 1,463 citations
• Subtype-specific genomic alterations define new targets for soft tissue sarcoma therapy (2010) — 718 citations
• Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain (2005) — 3,566 citations
• EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. (2004) — 3,941 citations
• Casein Kinase Iε Modulates the Signaling Specificities of Dishevelled (2004) — 135 citations
• Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes. (2001) — 618 citations